Medicine
Lamivudine 100 mg tablet
Lamivudine 100 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Lamivudine
- Brand
- Sold under the generic name
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 20 blister pack, 60 tablets, 600 tablets and 5 more
- Manufacturers
- Camber PharmaceuticalsIndiaApotexGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AF05 Lamivudine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 January 2014
- Identifiers
- RxCUI 205328DailyMed set ID e90671c6-7fff-48f4-8898-29f02d049c8b, 6bd6b9da-df69-46db-813e-4e7f3bdecf95, 87095352-c088-74b1-7be0-d3e293a90611 +1NDC 31722-001, 31722-752, 60505-3250 +1Application ANDA211306, ANDA203260, ANDA202941
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 20 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 31722-001-02 | Camber PharmaceuticalsIndia | 21 March 2019 |
| 60 tablet, film coated in 1 bottle | 31722-001-60 | Camber PharmaceuticalsIndia | 21 March 2019 |
| 600 tablet, film coated in 1 bottle | 31722-752-06 | Camber PharmaceuticalsIndia | 2 January 2014 |
| 10 tablet, film coated in 1 blister pack | 31722-752-31 | Camber PharmaceuticalsIndia | 2 January 2014 |
| 100 tablet, film coated in 1 carton | 31722-752-32 | Camber PharmaceuticalsIndia | 2 January 2014 |
| 60 tablet, film coated in 1 bottle | 31722-752-60 | Camber PharmaceuticalsIndia | 2 January 2014 |
| 60 tablet, film coated in 1 bottle | 60505-3250-6 | Apotex | 3 January 2014 |
| 60 tablet, film coated in 1 bottle | 51407-866-60 | Golden State Medical Supply | 9 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Lamivudine
Clinical summary
Lamivudine is a hepatitis B virus nucleoside analog reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It is available as tablets and oral solution. MedsAcross supplies Lamivudine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LamivudineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EPIVIR prescribing information (ViiV Healthcare) · U.S. National Library of Medicine, DailyMed
- Epivir: European public assessment report (EPAR) · European Medicines Agency
- Zeffix: European public assessment report (EPAR) · European Medicines Agency
Need Lamivudine 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.